The Effect of Cardiac Rehabilitation Combined with Coenzyme Q10 in Patients with Heart Failure

The Effect of Cardiac Rehabilitation Combined with Coenzyme Q10 in Patients with Heart Failure

The Effect of Cardiac Rehabilitation Exercises Combined with Coenzyme Q10 on Functional Capacity and Ejection Fraction in Patients with Chronic Heart Failure

Cardiovascular problems are the leading cause of disease and mortality worldwide, and heart failure is the third leading cause of death in this context. It is associated with a decrease in ATP and mitochondrial dysfunction in cardiac cells, leading to metabolic pathway disruptions, reduced energy, and negative effects on cardiac contractile function.

Factors Preventing Heart Energy Reduction
Therapeutic factors that can prevent heart energy reduction may play a role in treating and controlling heart failure. The increasing prevalence of heart failure in society is a major healthcare challenge. High blood pressure, coronary artery disease, weakened heart muscles, valvular disease, and arrhythmias increase the likelihood of heart failure.

Prevention of Coronary Artery Disease
There is substantial evidence that prognosis and quality of life for patients with cardiovascular disease can be improved with lifestyle changes and pharmacotherapy. Regular, moderate-intensity exercise is one such measure that can help prevent coronary artery disease, which is supported by the World Health Organization. Increased physical activity leads to improved physical and mental health and reduced mortality.

Impact of Physical Activity on Cardiovascular Events
Cardiopulmonary endurance improves after an exercise regimen, as seen in exercise tests, with a marked reduction in subsequent cardiovascular events, both fatal and non-fatal, independent of risk factors. This finding also applies to patients with chronic heart failure. In line with this, cardiac rehabilitation centers, where heart failure patients engage in exercise under the supervision of skilled physicians and nurses, have been established.

Drugs for Heart Failure Management
There are also medications to control heart failure, such as ACE inhibitors, angiotensin receptor blockers, beta-blockers, diuretics, and digoxin. Despite these drugs reducing disease and mortality, chronic symptoms such as fatigue and exercise intolerance remain a challenge. New treatments aimed at regulating heart energy have gained attention.

Coenzyme Q10
Coenzyme Q10, with a structure similar to vitamin K, may improve endothelial function due to its role in facilitating energy production in the mitochondrial electron transport chain and its anti-inflammatory properties. In heart failure patients, plasma Coenzyme Q10 is an independent predictor of mortality, with lower levels observed in those with advanced heart failure symptoms and reduced ejection fraction. This highlights the importance of Coenzyme Q10 supplementation.

Impact of Coenzyme Q10
Recent studies suggest that heart failure is a state of reduced energy due to the harmful effects of reactive oxygen species and oxidative stress, leading to cellular damage and endothelial dysfunction. It has been proposed that Coenzyme Q10, due to its strong antioxidant effects and minimal drug interactions, can reduce toxic effects and potentially decrease mortality in heart failure patients. However, this is a controversial issue. This study aims to investigate the effect of cardiac rehabilitation exercises combined with Coenzyme Q10 as adjunctive treatment on functional capacity and ejection fraction (left ventricular function) in patients.

Studies
Exercise capacity is a very important factor in diagnosing improvement in cardiovascular patients. It also predicts mortality in heart patients. Regular exercise increases work capacity, with hundreds of studies showing that exercise capacity is higher in active individuals compared to sedentary ones. Improvement in exercise tolerance through an exercise program has numerous benefits, including better capacity to handle daily activities, progress in returning to work, and improved quality of life. Studies show that both individuals with cardiovascular disease and healthy individuals experience better lives with higher exercise capacity. Improvements in exercise capacity through exercise can range from 5% to 25%, but increases of over 50% have also been reported.

Factors Affecting Changes in Exercise Capacity
The extent of change in exercise capacity essentially depends on the individual’s initial fitness level, age, gender, as well as the intensity and frequency of exercise. In fact, exercise increases oxygen release in the myocardium by changing vascular nerve responses, and it is important to note that every increase in exercise capacity leads to a 12% increase in survival.

Research
Two other studies showed that daily consumption of 300 mg of Coenzyme Q10 for two years and 200 mg for four months significantly improved the NYHA functional classification and reduced mortality in the test group compared to the placebo group. Researchers found that after taking Coenzyme Q10, functional capacity and left ventricular contractility increased without side effects, and its combination with exercise had a significant impact on patients. Overall, the results of most studies align with these findings. However, due to the heterogeneity and small size of the studies and the lack of consistency in methods and cardiovascular drugs used, meaningful conclusions and widespread recommendations for Coenzyme Q10 use remain limited.

Mechanism of Coenzyme Q10 Action
Nevertheless, considering the mechanism of action of Coenzyme Q10, its positive effects cannot be overlooked. Coenzyme Q10 acts as a strong antioxidant in cell membranes and lipoproteins and is the only antioxidant synthesized in the body. By preventing lipid peroxidation, it can play an essential role in stabilizing cell membranes and reducing cellular damage. It has been recognized in recent years for its key role in mitochondrial biogenesis, acting as an electron carrier in mitochondria and as an essential cofactor for energy production. Internal synthesis and dietary intake prevent deficiency in healthy individuals. However, levels and the ability to produce Coenzyme Q10 in tissues decrease with age and in the hearts of heart failure patients, so its deficiency exacerbates the condition.

Impact of Oral Coenzyme Q10 Supplementation
Oral Coenzyme Q10 supplementation increases its plasma levels, lipoproteins, and blood vessels. However, it is unclear whether Coenzyme Q10 levels in tissues, particularly in patients, increase. Although this supplement may serve as adjunctive treatment alongside conventional therapies for heart failure patients, its impact on cardiovascular patients requires further investigation. It is suggested that the harmful effects of reactive oxygen species increase in heart failure patients, and Coenzyme Q10, due to its antioxidant activity, can help reduce toxic effects. Plasma Coenzyme Q10 levels are an independent predictor of mortality in heart patients. Moreover, Coenzyme Q10 may play a role in myocardial calcium stability (depending on ion channels) and membrane stability, preventing the loss of metabolites required for ATP synthesis.

Research Trends
Based on the findings from previous studies and the mechanisms discussed, Coenzyme Q10 may act as a strong antioxidant, improving endothelial function without side effects or increasing heart energy production, thus improving functional capacity and ejection fraction.

Improvement in Patients
This improvement was more pronounced in patients who participated in rehabilitation programs combined with Coenzyme Q10 supplementation. Cardiac rehabilitation, particularly when combined with Coenzyme Q10, led to better left ventricular function with increased EF and METs in heart patients.

Our Recommendation
It is recommended that cardiac therapists, based on evidence of safe and effective cardiovascular benefits, encourage patients to engage in simultaneous cardiac rehabilitation and Coenzyme Q10 supplementation.

Research Suggestions
Furthermore, future studies with larger numbers of participants receiving Coenzyme Q10 and exercise over longer periods and at varying doses are needed to better understand the role of exercise and supplements in improving these desired outcomes. This will enable more reliable conclusions regarding the efficacy of Coenzyme Q10 supplementation and exercise in the rehabilitation of heart patients. Finding an appropriate exercise and medication protocol for heart patients is challenging, and perhaps exercise protocols with varying intensity and duration may be suitable for individuals with different ages and disease characteristics.

Solution
Additionally, understanding which cellular and molecular mechanisms are involved in cardiovascular adaptations induced by exercise and supplements will help specialists use drugs or other therapeutic methods to assist heart patients in prevention and treatment.

Source
Esteghli, Samira, Ebrahim, Khosrow, Gholami, Mandana, & Jalalian, Rezita. (2017). The effect of cardiac rehabilitation exercises combined with Coenzyme Q10 on functional capacity and ejection fraction in patients with chronic heart failure. Journal of the Faculty of Medicine, Mashhad University of Medical Sciences, 60(6), 756-766. SID.

The Effect of Carnitine on Hemodialysis Patients

The Effect of Carnitine on Hemodialysis Patients

Cardiovascular diseases are considered the leading cause of mortality among hemodialysis patients. Hypertension, advanced age, diabetes, and other systemic diseases that affect cardiac function are commonly seen in these patients. This article will examine the effects of carnitine on hemodialysis patients.

Additionally, hemodialysis patients often suffer from deficiencies in some essential substances required for the metabolic functions of myocardial cells.

Introduction to Carnitine

Carnitine is a natural substance with its primary physiological role in the body:

It facilitates the transport of long-chain fatty acids from the cytoplasm into mitochondria for their beta-oxidation.
Therefore, sufficient carnitine within cells is essential for the normal metabolism of fatty acids in the human body. This is especially important in tissues like the heart and skeletal muscles, which depend on fatty acid metabolism to produce energy.

Key Features and Roles of Carnitine

  1. Fat Metabolism: Carnitine plays a role in transporting fatty acids into mitochondria for beta-oxidation (the process of producing energy from fatty acids). This process is essential for energy production in daily activities.
  2. Support for the Cardiovascular System: The heart, as the main blood pump in the human body, requires a constant supply of energy. Carnitine helps by transporting fatty acids into the mitochondria of the myocardium (heart muscle), improving energy supply and potentially improving cardiovascular function.
  3. Regulation of Glucose Metabolism: The breakdown of fats by carnitine can help reduce glucose utilization as an energy source, which may be beneficial in improving blood sugar control.
  4. Oxidative Balance: Carnitine acts as a natural antioxidant, helping to maintain oxidative balance within cells and preventing oxidative damage.
  5. Body Composition Support: Carnitine supplementation can help reduce abdominal fat and improve overall body composition.

Biological Function in Humans

In the human biological system, carnitine exists in two forms:

  1. Free form
  2. Esterified form

In hemodialysis patients, unlike healthy individuals, the esterified form of carnitine is more prevalent than the free form. This is due to the loss of free carnitine through the dialysis membrane. As a result, despite normal plasma levels of total carnitine, the accumulation of the esterified form and the reduction in free carnitine leads to lower carnitine levels in tissues (including the heart and skeletal muscles).

Effects of Carnitine Administration

Various studies have investigated the effects of carnitine administration (either intravenously or orally) in hemodialysis patients or those with heart failure. One such study found that carnitine had a significant effect on improving anemia in hemodialysis patients.

Effects of Low Dose Oral Carnitine Administration

A study conducted by researchers showed that administering a low dose of oral L-carnitine (500 mg per day) for six months resulted in improvement in:

  • Patient symptoms
  • Increased LVEF (Left Ventricular Ejection Fraction)
  • Decreased left ventricular mass

Given the mixed results regarding the effects of carnitine on cardiac function, further studies are necessary to evaluate its impact on heart function.

Results on the Cardiac Systolic Function in Hemodialysis Patients with Heart Failure

This study, conducted on hemodialysis patients, examined the effect of oral carnitine administration on the systolic function of the heart in these patients with heart failure.

In addition, the impact of carnitine administration on:

  • Cardiac symptoms
  • Anemia
  • Hyperlipidemia

was also assessed simultaneously in these patients. A total of 20 patients participated in the study, divided into control and intervention groups. They were studied for six months.

Inclusion criteria for the patients were having an LVEF (Left Ventricular Ejection Fraction) of less than 50%. Patients with heart failure due to other specific causes, such as congenital heart diseases or valvular heart disorders, were excluded from the study. After adjusting for variables such as:

  • Age
  • Gender
  • Cause of kidney failure
  • Hypertension
  • Diabetes, etc.

patients were randomly assigned to the intervention and control groups.

Drug Administration to Patients

After selecting patients and dividing them into two groups (intervention and control), the intervention group was given 250 mg carnitine tablets with a dose of 1 gram per day.

The control group received a placebo in the same form as the carnitine but without carnitine.

Other medications commonly used by these patients, including:

  • Rokatrol tablets
  • Ferrous sulfate tablets
  • Calcium carbonate tablets
  • Folic acid tablets
  • Eprex injections
  • Antihypertensive medications

were continued, and no changes were made to the doses. Efforts were made to ensure the medication types were similar between the two groups.

Results Regarding Ejection Fraction

The results obtained regarding:

  • Ejection fraction
  • Left ventricular end-diastolic diameter
  • The ratio of cardiac diameter to chest diameter on chest X-ray
  • Hemoglobin levels
  • Triglycerides
  • Plasma cholesterol

were compared using repeated-measures analysis of variance and Bonferroni post-hoc tests. To compare between the two groups, Student’s t-test was used.

According to the studies, low-dose oral carnitine (500 mg/day for six months) significantly improved cardiac symptoms and function in hemodialysis patients.

Conclusion

The difference in the results of this study compared to previous research might be due to:

  • The ejection fraction level, which in our study was set to less than 50%, whereas in the Matsumoto study it was set to less than 60%. This means the cardiac function of patients in our study was lower initially.
  • The carnitine dose in their study was almost half of the dose used in our study.

Another study examined the effect of intravenous carnitine on serum triglyceride levels and showed that carnitine is effective only in patients with hypertriglyceridemia.

Research Results

According to the studies, only oral carnitine has a significant and beneficial effect on improving anemia. Researchers found that carnitine helps:

  • Reduce fatigue
  • Increase exercise tolerance

Given the importance of cardiovascular problems in hemodialysis patients, which is the leading cause of mortality in these patients, further studies are necessary to evaluate the effect of carnitine in improving the cardiac condition of these patients.